キャンピロバクター腸炎 in ブリュッセル

Same author

Traitement Des Infections Bronchopulmonaires Aigues Par Le Laurylsulfate De Tetracycline Intra-Musculaire.

Acta clinica Belgica·2016

Same author

Prevalence of subtilase cytotoxin in verocytotoxin-producing Escherichia coli isolated from humans and raw meats in Belgium.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2010

Same author

Correction of underquantification of human immunodeficiency virus type 1 load with the second version of the Roche Cobas AmpliPrep/Cobas TaqMan assay.

Journal of clinical microbiology·2010

Same author

The in-vitro activity of ceftazidime: comparison with other beta-lactam antibiotics.

The Journal of antimicrobial chemotherapy·2009

Same author

Use of ceftazidime in severe Gram-negative infections--a preliminary study.

The Journal of antimicrobial chemotherapy·2009

Same author

First sorbitol-fermenting Verocytotoxin-producing Escherichia coli O157: H- isolated in Belgium.

Acta clinica Belgica·2009

Same journal

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Lancet (London, England)·2026

Same journal

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Lancet (London, England)·2026

Same journal

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Lancet (London, England)·2026

Same journal

Documenting hospice care.

Lancet (London, England)·2026

Same journal

After the wood chipper.

Lancet (London, England)·2026

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

関連する実験動画

キャンピロバクター腸炎 in ブリュッセル

関連する概念動画

Traitement Des Infections Bronchopulmonaires Aigues Par Le Laurylsulfate De Tetracycline Intra-Musculaire.

Prevalence of subtilase cytotoxin in verocytotoxin-producing Escherichia coli isolated from humans and raw meats in Belgium.

Correction of underquantification of human immunodeficiency virus type 1 load with the second version of the Roche Cobas AmpliPrep/Cobas TaqMan assay.

The in-vitro activity of ceftazidime: comparison with other beta-lactam antibiotics.

Use of ceftazidime in severe Gram-negative infections--a preliminary study.

First sorbitol-fermenting Verocytotoxin-producing Escherichia coli O157: H- isolated in Belgium.

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Documenting hospice care.

After the wood chipper.

Assisted dying and the silencing of medicine's next generation.

関連する実験動画

キャンピロバクター腸炎 in ブリュッセル

関連する概念動画

関連記事

Traitement Des Infections Bronchopulmonaires Aigues Par Le Laurylsulfate De Tetracycline Intra-Musculaire.

Prevalence of subtilase cytotoxin in verocytotoxin-producing Escherichia coli isolated from humans and raw meats in Belgium.

Correction of underquantification of human immunodeficiency virus type 1 load with the second version of the Roche Cobas AmpliPrep/Cobas TaqMan assay.

The in-vitro activity of ceftazidime: comparison with other beta-lactam antibiotics.

Use of ceftazidime in severe Gram-negative infections--a preliminary study.

First sorbitol-fermenting Verocytotoxin-producing Escherichia coli O157: H- isolated in Belgium.

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Documenting hospice care.

After the wood chipper.

Assisted dying and the silencing of medicine's next generation.